This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Biora Therapeutics, Inc.
3/30/2023
Thank you for standing by. This is the conference operator. Welcome to the BioAura Therapeutics Fourth Quarter 2022 Financial Results Conference Call. As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. To join the question queue, you may press star then 1 on your telephone keypad. Should you need assistance during the conference call, You may signal an operator by pressing star and zero. I would now like to turn the conference over to Chuck Padala, Managing Director with Life Sci-Fi Advisors, Bayora's Investors Relations Firm.
Please, Chuck, go ahead.
Thank you, Operator.
You're reading a preview of the BIOR Q4 2022 earnings call.
Free account.